Founded in Los Angeles, California, Flotherm is dedicated to improving surgical outcomes through advanced perioperative warming technologies. The company's core mission is to address the unmet clinical need of inadvertent perioperative hypothermia, a condition where a patient's core temperature drops below 36°C during surgery due to anesthesia and lack of preoperative warming. Flotherm's flagship product is a thermal compression device designed to maintain normothermia efficiently and effectively, ensuring patient safety and enhancing recovery times.
Flotherm has garnered attention for its innovative approach to perioperative care, attracting notable investors and medical professionals who recognize the critical impact of maintaining normothermia. The company has achieved significant milestones in clinical trials, demonstrating the efficacy of its device in preventing hypothermia-related complications. Through its cutting-edge technology, Flotherm is poised to make a substantial impact on the healthcare industry by setting new standards for patient management and surgical care.
